Tony W. Ho, Executive VP, Head of R&D at CRISPR Therapeutics AG (CRSP), sold 14,087 shares at $75.20 ($1.1M) on 2020-06-23, disclosed to the SEC on 2020-06-24.
Open-market sale of $1.1M CRSP by Executive VP, Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.14 | 229 | $16K | 1.5% |
| 2 | $75.20 | 6,929 | $521K | 49.2% |
| 3 | $75.20 | 6,929 | $521K | 49.2% |
| Total | $75.12 avg | 14,087 | $1.1M | 100% |
| Filing → |